Prostate Cancer Screening
Debate between Andrew Murrison and Luke Evans(3 days, 10 hours ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Dr Luke Evans (Hinckley and Bosworth) (Con)
Many in this House will know my previous position, but I will use my speech to talk about things I understand and things I do not.
I understand why there is such a drive to pick up the screening programme. The numbers have been stated explicitly, and I understand why the Government are citing the evidence from the committee to make sure that this is measured. If there is a test that says someone may have cancer 75% of the time but does not pick it up 15% of the time, that is a matter of concern, especially when we read the statistics about 12 men in 1,000 tested being overtreated. Nobody has talked about what being overtreated means; it means a man who is perhaps 56 and asymptomatic suddenly suffering erectile dysfunction, though he never had a cancer that needed treatment. These are important points, and it is right that we expand the trial to understand more about what is going on.
Here is what I do not understand, which I will put to the Minister. The guidance for GPs has changed: formerly, when a man who was asymptomatic and over 50 requested a PSA, they could get it. We have a test that is not very good, and it is hard enough to get men in to see a doctor, but what are they most concerned about? Cancer. I have had those conversations; they understand the risks and still want that test. Why have the Government changed that, when their own consultation says:
“There was no simple way of knowing from the data whether a PSA test had been done because of a patient’s request for one, a GP’s concern about a patient’s symptoms, as part of post-cancer treatment follow-up, or active surveillance”?
The Government do not even know why PSA test access was changed. That is important. If a man goes in to ask for a PSA test, given everything he knows, he should have the right to that test until we get further information to tell him otherwise, because if I was that GP, I would be worried he would ask for my General Medical Council number and my name.
Dr Andrew Murrison (in the Chair)
I thank Members for their timekeeping and call Perran Moon.